| [1] |
中华医学会感染病学分会艾滋病学组，Diseases SoI，Association CM. 艾滋病诊疗指南第三版(2015版)[J]. 中华临床感染病杂志,2015,8(5):385-401.
|
| [2] |
Masur H, Brooks JT, Benson CA, et al. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated guidelines from the centers for disease control and prevention, national institutes of health, and HIV medicine association of the infectious diseases society of America[J]. Clini Infect Dis,2014,58(9):1308-1311.
|
| [3] |
岳青，刘玉芬，李健, 等. 2009-2017年医疗机构新报告HIV感染者和艾滋病患者晚发现情况分析[J]. 中华预防医学杂志,2018,52(12):1248-1253.
|
| [4] |
陶静，洪亮，王绪琴, 等. 1例艾滋病感染早期诊断检测方法的研究[J]. 健康教育与健康促进,2018,13(6):562-564.
|
| [5] |
O’Connell S, Enkelmann J, Sadlier C, et al. Late HIV presentation-missed opportunities and factors associated with a changing pattern over time[J]. Int J STD AIDS,2017,28(8):814-821.
|
| [6] |
Bowen LN, Smith B, Reich D, et al. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment[J]. Nat Rev Neurol,2016,12(11):662-674.
|
| [7] |
Ellis J, Cresswell FV, Rhein J, et al. Cryptococcal meningitis and tuberculous meningitis co-infection in HIV-infected ugandan adults[J]. Open Forum Infect Dis,2018,5(8):ofy193.
|
| [8] |
Yang R, Zhang H, Xiong Y, et al. Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China[J]. AIDS Res Ther,2017,14(1):24-30.
|
| [9] |
何才通. 艾滋病合并结核病及隐球菌脑膜炎11例临床分析[J]. 广西医学,2010,32(9):1162-1164.
|
| [10] |
赵川，许利军，唐坤伦, 等.艾滋病合并新型隐球菌脑膜炎16例临床分析[J]. 西部医学,2012,24(10):1955-1957.
|
| [11] |
中华医学会感染病学分会艾滋病学组，中华医学会热带病与寄生虫学分会艾滋病学组. HIV合并结核分枝杆菌感染诊治专家共识[J]. 中华临床感染病杂志,2017,10(2):81-90.
|
| [12] |
鲁雁秋，邱丹，陈耀凯. 艾滋病合并新型隐球菌性脑膜炎患者的综合治疗[J]. 中华临床感染病杂志,2018,11(2):156-160.
|
| [13] |
方敏，邓梅花，梁飞立. HIV感染抗逆转录病毒治疗时机的研究进展[J/CD]. 中华实验和临床感染病杂志(电子版),2016,10(2):136-139.
|
| [14] |
WHO Guidelines Approved by the Guidelines Review Committee[A]. In: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach (Nd, ed)[M]. Geneva: World Health Organization Copyright (c),2016.
|
| [15] |
卜岚，白轩. HIV/AIDS合并肺结核患者抗结核分枝杆菌治疗肝毒性的危险因素[J/CD]. 中华实验和临床感染病杂志(电子版),2018,12(2):183-188.
|
| [16] |
Boulle A, Van Cutsem G, Cohen K, et al. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy[J]. JAMA,2008,300(5):530-539.
|
| [17] |
Soriano V. Update of the DHHS antiretroviral treatment guidelines[J]. AIDS Rev,2014,16(2):117-118.
|
| [18] |
田云飞，肖江，韩宁, 等. HIV/AIDS患者高效抗逆转录病毒治疗后免疫重建不良的特征及相关因素分析[J]. 国际病毒学杂志,2014,21(4):145-150.
|
| [19] |
田云飞，肖江，韩宁, 等. HIV/AIDS患者免疫重建不良的研究进展[J/CD]. 中华实验和临床感染病杂志(电子版),2015,8(4):462-467.
|
| [20] |
张红，熊勇，高世成, 等 艾滋病合并中枢神经系统病变的临床分析[J/CD]. 中华实验和临床感染病杂志(电子版),2015,9(2):201-205.
|